81 related articles for article (PubMed ID: 11145839)
1. BLyS BINDS TO B CELLS WITH HIGH AFFINITY AND INDUCES ACTIVATION OF THE TRANSCRIPTION FACTORS NF-kappaB AND ELF-1.
Kanakaraj P; Migone TS; Nardelli B; Ullrich S; Li Y; Olsen HS; Salcedo TW; Kaufman T; Cochrane E; Gan Y; Hilbert DM; Giri J
Cytokine; 2001 Jan; 13(1):25-31. PubMed ID: 11145839
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
3. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of BLyS receptor recognition.
Oren DA; Li Y; Volovik Y; Morris TS; Dharia C; Das K; Galperina O; Gentz R; Arnold E
Nat Struct Biol; 2002 Apr; 9(4):288-92. PubMed ID: 11862220
[TBL] [Abstract][Full Text] [Related]
5. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity.
Yan M; Marsters SA; Grewal IS; Wang H; Ashkenazi A; Dixit VM
Nat Immunol; 2000 Jul; 1(1):37-41. PubMed ID: 10881172
[TBL] [Abstract][Full Text] [Related]
6. Discovery of high-affinity peptide binders to BLyS by phage display.
Fleming TJ; Sachdeva M; Delic M; Beltzer J; Wescott CR; Devlin M; Lander RC; Nixon AE; Roschke V; Hilbert DM; Sexton DJ
J Mol Recognit; 2005; 18(1):94-102. PubMed ID: 15382264
[TBL] [Abstract][Full Text] [Related]
7. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
[TBL] [Abstract][Full Text] [Related]
8. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB.
Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV
Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes.
Karpusas M; Cachero TG; Qian F; Boriack-Sjodin A; Mullen C; Strauch K; Hsu YM; Kalled SL
J Mol Biol; 2002 Feb; 315(5):1145-54. PubMed ID: 11827482
[TBL] [Abstract][Full Text] [Related]
12. B-Lymphocyte stimulator: a new biomarker for multiple myeloma.
Jiang P; Yueguo W; Huiming H; Hongxiang Y; Mei W; Ju S
Eur J Haematol; 2009 Apr; 82(4):267-76. PubMed ID: 19187273
[TBL] [Abstract][Full Text] [Related]
13. Construction and function of two Cys146-mutants with high activity, derived from recombinant human soluble B lymphocyte stimulator.
Chen G; Peng S; Zou M; Xu H; Xu D; Wang J
J Biochem; 2004 Jul; 136(1):73-9. PubMed ID: 15269242
[TBL] [Abstract][Full Text] [Related]
14. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
15. Optimization of BLyS production and purification from Escherichia coli.
Laird MW; Sampey GC; Johnson K; Zukauskas D; Pierre J; Hong JS; Cooksey BA; Li Y; Galperina O; Karwoski JD; Burke RN
Protein Expr Purif; 2005 Feb; 39(2):237-46. PubMed ID: 15642475
[TBL] [Abstract][Full Text] [Related]
16. BLyS--an essential survival factor for B cells: basic biology, links to pathology and therapeutic target.
Baker KP
Autoimmun Rev; 2004 Jul; 3(5):368-75. PubMed ID: 15288003
[TBL] [Abstract][Full Text] [Related]
17. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
[TBL] [Abstract][Full Text] [Related]
18. A novel BLyS antagonist peptide designed based on the 3-D complex structure of BCMA and BLyS.
Sun J; Feng J; Li Y; Shen B
Biochem Biophys Res Commun; 2006 Aug; 346(4):1158-62. PubMed ID: 16793005
[TBL] [Abstract][Full Text] [Related]
19. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1.
Xu LG; Wu M; Hu J; Zhai Z; Shu HB
J Leukoc Biol; 2002 Aug; 72(2):410-6. PubMed ID: 12149433
[TBL] [Abstract][Full Text] [Related]
20. Hepatic expression of the tumor necrosis factor family member lymphotoxin-beta is regulated by interleukin (IL)-6 and IL-1beta: transcriptional control mechanisms in oval cells and hepatoma cell lines.
Subrata LS; Lowes KN; Olynyk JK; Yeoh GC; Quail EA; Abraham LJ
Liver Int; 2005 Jun; 25(3):633-46. PubMed ID: 15910501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]